Xiong Guo-Bao, Yao Wen-Liang, Wu Fei-Hua
Reproductive Center, Affiliated Hospital of Nanchang Institute of Medical Sciences, Nanchang, Jiangxi 330001, China.
Zhonghua Nan Ke Xue. 2009 Dec;15(12):1138-41.
To observe the clinical efficacy of Shenfu Qiangjing Decoction (SQD) in the treatment of non-inflammatory and non-liquefied semen in infertile males with kidney-yang deficiency.
Sixty cases of male infertility caused by non-inflammatory and non-liquefied semen with kidney-yang deficiency were equally and randomly divided into an SQD and a control group, the former given oral SQD and the latter vitamin C tablets plus intramuscular chymotrypsin. Both groups were observed for sperm viability, sperm motility, serum testosterone, seminal plasma PSA and improvement of kidney-yang deficiency symptoms before and after the medication. The therapeutic effects were evaluated according to the semen liquefaction within 60 min.
Statistically significant differences were observed in the improvement of kidney-yang deficiency symptoms after the medication between the SQD and control groups (P < 0.01, P < 0.05) , and in sperm viability and motility of the SQD group before and after the treatment (P < 0.01) as well as between the two groups after the medication (P < 0.05). The levels of serum T and seminal plasma PSA also showed significant differences before and after the treatment in the SQD group (P < 0.01) and between the two groups after the medication (P < 0.05). The rate of total effectiveness was 93.3% in the SQD and 76.7% in the control group (P < 0.05).
SQD can shorten the semen liquefaction time in patients with non-inflammatory and non-liquefied semen and restore semen liquefaction to normal in over 90% of the patients. Meanwhile it can also improve the low testosterone level resulting from various kidney-yang deficiency symptoms.
观察参附强精汤治疗肾阳亏虚型男性不育症非炎性非液化精液的临床疗效。
将60例因非炎性非液化精液所致肾阳亏虚型男性不育症患者,随机分为参附强精汤组和对照组,每组各30例。参附强精汤组口服参附强精汤,对照组口服维生素C片并肌内注射糜蛋白酶。观察两组患者用药前后精子活率、精子活力、血清睾酮、精浆前列腺特异性抗原(PSA)及肾阳虚症状改善情况,以精液60分钟内液化情况评价疗效。
参附强精汤组与对照组用药后肾阳虚症状改善情况比较,差异有统计学意义(P<0.01,P<0.05);参附强精汤组治疗前后精子活率、精子活力比较,差异有统计学意义(P<0.01),且与对照组用药后比较,差异有统计学意义(P<0.05)。参附强精汤组治疗前后血清睾酮及精浆PSA水平比较,差异有统计学意义(P<0.01),且与对照组用药后比较,差异有统计学意义(P<0.05)。参附强精汤组总有效率为93.3%,对照组为76.7%,两组比较差异有统计学意义(P<0.05)。
参附强精汤能缩短非炎性非液化精液患者精液液化时间,使90%以上患者精液液化恢复正常,同时可改善因肾阳虚诸症导致的睾酮水平低下。